Nike’s fourth-quarter revenue nearly doubled, topping $12 billion for the first time and overshadowing a weaker-than-anticipated performance in its fast-growing China market.

A rapid vaccination drive and the easing of restrictions in Europe and the United States have encouraged people to go on a shopping spree, unleashing demand for expensive items, including sneakers.

Those factors helped Nike more than make up for weak China sales, which were hit by calls to boycott global brands for their comments around forced labor in Xinjiang.

Still, analysts are optimistic of a swift demand rebound in the region as company executives noted that sales trends in China for June were already reaching 2020 levels.

At least 13 brokerages raised their price targets, with Stifel's $213 target the highest on the Street. The median target is $175.

Nike's shares were trading at $152.10, after hitting an all-time high of $154.18 earlier. The jump also helped push the S&P 500 index to a record high, while lifting shares of German peers Adidas and Puma about 6 per cent and 2 per cent, respectively.